The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor.EBI
Pfizer
Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor.EBI
Genomics Institute of The Novartis Research Foundation
Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists.EBI
Pfizer
Novel indoline-1- or 3,4-dihydroquinoline-1(2H)-substituted carbothiohydrazides as TPO receptor agonists.EBI
Shanghai Hengrui Pharmaceuticals
Synthesis and biological evaluation of oxoindolin-3-ylidene ethyl benzothiohydrazides as non-peptide TPO mimics.EBI
Shanghai Hengrui Pharmaceuticals
The identification of orally bioavailable thrombopoietin agonists.EBI
Pfizer
Optimization of small molecule agonists of the thrombopoietin (Tpo) receptor derived from a benzo[a]carbazole hit scaffold.EBI
Genomics Institute of The Novartis Research Foundation
Pyrimidine benzamide-based thrombopoietin receptor agonists.EBI
Pfizer
New benzimidazoles as thrombopoietin receptor agonists.EBI
Glaxosmithkline
Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis.EBI
Glaxosmithkline